Section Arrow
ZBIO.NASDAQ
- Zenas Biopharma Inc.
Quotes are at least 15-min delayed:2026/01/08 17:08 EST
After Hours
Last
 16.41
0 (0.00%)
Bid
16.36
Ask
16.47
High 16.51 
Low 16.33 
Volume 5.40K 
Regular Hours (Closed)
Last
 16.41
-0.1 (-0.61%)
Day High 
17.15 
Prev. Close
16.51 
1-M High
44.6 
Volume 
809.98K 
Bid
16.36
Ask
16.47
Day Low
15.8 
Open
16.37 
1-M Low
13.5 
Market Cap 
886.24M 
Currency 美元 
P/E 1.18 
%Yield -- 
10-SMA 32.32 
20-SMA 35.01 
50-SMA 34.91 
52-W High 44.6 
52-W Low 5.83 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
13.67/-2.85
Enterprise Value
886.46M
Balance Sheet
Book Value Per Share
3.66
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
5.00M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1033-0.0223-17.75%-- 
After Hours 0.101 -0.0023 -2.23%
ACRVAcrivon Therapeutics1.93-1.02-34.58%-- 
After Hours 1.95 +0.02 +1.04%
VTYXVentyx Biosciences13.84+0.11+0.80%-- 
After Hours 13.8 -0.04 -0.29%
MLTXMoonLake Immunotherapeutics14.34+3.05+27.02%-- 
After Hours 14.48 +0.14 +0.98%
CRMDCorMedix7.51-3.66-32.77%5.05PE
After Hours 7.57 +0.06 +0.80%
Industry overview quotes are at least 15 minutes delayed
Business Description
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.